PUBLISHER: The Business Research Company | PRODUCT CODE: 1694867
PUBLISHER: The Business Research Company | PRODUCT CODE: 1694867
Radiosurgery and radiotherapy robotics encompass medical procedures that utilize advanced technology to precisely administer radiation doses to targeted areas of the body. These procedures are employed to treat a variety of medical conditions and play a pivotal role in contemporary healthcare. The integration of robotics enhances the precision and effectiveness of cancer treatment, while minimizing harm to adjacent healthy tissues.
The primary product categories within radiosurgery and radiotherapy robotics include those based on X-rays, gamma-rays, and proton beams. X-rays are a form of high-energy electromagnetic radiation that can penetrate most substances. These products find application in various treatments, encompassing external beam radiotherapy, internal beam radiotherapy (brachytherapy), and are employed by healthcare facilities such as hospitals and clinics.
The radiosurgery and radiotherapy robotics market research report is one of a series of new reports from The Business Research Company that provides radiosurgery and radiotherapy robotics market statistics, including radiosurgery and radiotherapy robotics industry global market size, regional shares, competitors with a radiosurgery and radiotherapy robotics market share, detailed radiosurgery and radiotherapy robotics market segments, market trends and opportunities and any further data you may need to thrive in the radiosurgery and radiotherapy robotics industry. This radiosurgery and radiotherapy robotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The radiosurgery and radiotherapy robotics market size has grown steadily in recent years. It will grow from $4.36 billion in 2024 to $4.58 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to prevalence of cancer, demand for minimally invasive surgical techniques, increase in funding for medical robot research, global healthcare infrastructure.
The radiosurgery and radiotherapy robotics market size is expected to see strong growth in the next few years. It will grow to $5.75 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to aging population, rising acceptance of robotic technology, high tumor-treating effectiveness, government support for the radiosurgery, growing awareness of the benefits of radiosurgery and radiotherapy robots. Major trends in the forecast period include ai-assisted treatment planning, radiomics and big data analysis, remote consultations and telesurgery, nanotechnology integration, high technical of radiosurgery robotics development.
The rising prevalence of cancer is expected to drive the growth of the radiosurgery and radiotherapy robotics market in the coming years. Cancer refers to a group of diseases that can develop in nearly any part of the body when abnormal cells grow uncontrollably, spread to other organs, or invade nearby tissues. Radiosurgery and radiotherapy robotics are vital in cancer treatment, as they enable high precision, assist with accurate imaging and placement, and offer advanced therapeutic options for various types of cancer, including pancreatic cancer. For example, in February 2024, a report by the World Health Organization (WHO), a Switzerland-based intergovernmental organization, projected that the global cancer burden would rise to more than 35 million cases by 2050, marking a 77% increase from the 20 million cases estimated in 2022. Lung cancer was the most common, with 2.5 million new cases (12.4% of all new cases), followed by breast cancer in females (2.3 million cases, 11.6%), colorectal cancer (1.9 million, 9.6%), prostate cancer (1.5 million, 7.3%), and stomach cancer (970,000, 4.9%). As a result, the increasing incidence of cancer is driving the growth of the radiosurgery and radiotherapy robotics market.
The increasing demand for minimally invasive procedures (MIPs) is expected to drive the growth of the radiosurgery and radiotherapy robotics market. MIPs are surgical procedures that are performed through small incisions, using specialized instruments and cameras inserted into the body. Radiosurgery and radiotherapy robots are used in these procedures to deliver radiation more accurately and precisely than traditional methods, as robots can move with greater consistency and precision than humans. For example, in February 2024, the American Academy of Facial Plastic and Reconstructive Surgery, a US-based non-profit organization, reported that in 2023, 83% of medical procedures were minimally invasive, while only 17% were traditional surgeries. As a result, the growing preference for minimally invasive procedures is fueling the expansion of the radiosurgery and radiotherapy robotics market.
Leading companies in the radiosurgery and radiotherapy robotics market are actively embracing innovative technological solutions to maintain their competitive edge. One such advancement is the implementation of a dynamic surface positioning and monitoring system, designed for surface-guided radiation therapy (SGRT). This system employs a thermal-surface camera to continuously monitor patient positioning and detect any movement during the treatment process. For example, in May 2023, Brainlab, a Germany-based developer of software and hardware solutions for radiotherapy and radiosurgery, introduced the ExacTrac Dynamic Surface Positioning and Monitoring System. This single-camera unit solution ensures uniformity across radiation departments and enables ongoing patient monitoring, especially during breath-hold treatments. The primary objective of ExacTrac Dynamic Surface is to establish consistency throughout the department while delivering precise tracking. Clinicians can easily integrate ExacTrac Dynamic Surface into their workflows, benefiting from a short learning curve and a user-friendly interface that remains consistent across different linear accelerators.
In May 2022, Brainlab AG, a German medical technology company, completed the acquisition of medPhoton GmbH for an undisclosed sum. This strategic move is anticipated to enable Brainlab to broaden its range of innovative radiotherapy products. medPhoton GmbH, headquartered in Austria, specializes in radiosurgery and radiotherapy robotics and is renowned for its development and production of robotic imaging solutions tailored for image-guided radiation therapy and navigational surgery.
Major companies operating in the radiosurgery and radiotherapy robotics market are Mitsubishi Electric Corporation, Hitachi Ltd., Siemens Healthineers AG, Medtronic PLC, Elekta AB, Shinva Medical Instrument Co. Ltd., Neusoft Medical Systems Co. Ltd., Accuray Incorporated, Sumitomo Heavy Industries Ltd., Ion Beam Applications SA, Brainlab AG, ViewRay Inc., Zhuhai Hokai Medical Instruments Co. Ltd., RaySearch Laboratories AB, Mevion Medical Systems Inc., Vision Rt Limited, Sun Nuclear Corporation, Panacea Medical Technologies Pvt. Ltd., C-Rad AB, Radiadyne LLC, ProTom International Holding Corporation, CIVCO Radiotherapy, Standard Imaging Inc., Intraop Medical Corporation, Best Medical International Inc., Modus Medical Devices Inc., Mirada Medical Ltd.
North America was the largest region in the radiosurgery and radiotherapy robotics market in 2024. The regions covered in radiosurgery and radiotherapy robotics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the radiosurgery and radiotherapy robotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The radiosurgery and radiotherapy robotics market consists of sales of gamma knife, robotic arm, linear accelerator, imaging systems and TrueBeam system. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Radiosurgery And Radiotherapy Robotics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on radiosurgery and radiotherapy robotics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for radiosurgery and radiotherapy robotics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The radiosurgery and radiotherapy robotics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.